Glucag0n
Product Images NDC 51662-1323

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glucag0n (NDC 51662-1323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinical A (Clinical Pharma A)

A line graph depicting glucagon concentration (ng/ml) over time (hours) from dosing. The concentration rises sharply to a peak near 7 ng/ml shortly after dosing, then steadily declines to near zero by 3 hours post-dose. Error bars are shown at each time point.*

FDA Label Image

Clinical B (Clinical Pharma B)

A line graph labeled 'B' showing blood glucose concentrations (mg/dL) on the vertical axis over time (hours) on the horizontal axis, ranging from 0 to 4 hours. The graph depicts a rise in blood glucose levels peaking around 1 hour, followed by a decline and stabilization towards the end of the time period.*

FDA Label Image

Dosage (Dosage Table)

A table showing doses of GLUCAG0N with corresponding routes of administration, time of onset of action, and approximate duration of effect. It includes data for intravenous and intramuscular routes at doses from 0.25 mg to 2 mg, with onset times ranging from 1 to 10 minutes and durations from 9 to 32 minutes.*

FDA Label Image

Image 1 (Ifu 1)

Illustration showing a hand holding a vial or small container with a thumb positioned to pull off or remove the top cap, indicated by an upward arrow. This instructional diagram likely relates to the preparation or use of the drug GLUCAG0N by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Image 2 (Ifu 2)

An instructional line drawing showing hands preparing a syringe with a vial. One hand holds the vial upside down while the other hand inserts the syringe needle into the vial, indicated by a downward arrow. This illustration demonstrates the step of drawing medication from a vial using a syringe.*

FDA Label Image

Image 3 (Ifu 3)

An instructional line drawing showing a hand holding a small rectangular object with the thumb and index finger. Below the hand is a circular arrow indicating a twisting or rotating motion of the object in the hand.*

FDA Label Image

Image 4 (Ifu 4)

An instructional illustration showing a person preparing a syringe, with one hand holding a vial and the other pulling back the syringe plunger. A downward arrow indicates the direction to pull the plunger. This diagram is likely related to the preparation or administration of GLUCAG0N.*

FDA Label Image

Table 1 (Ifu Table 1)

A table listing symptoms organized in two columns. The left column includes symptoms such as sweating, dizziness, palpitation, tremor, hunger, restlessness, tingling in the hands, feet, lips, or tongue, lightheadedness, inability to concentrate, and headache. The right column includes drowsiness, sleep disturbances, anxiety, blurred vision, slurred speech, depressed mood, irritability, abnormal behavior, unsteady movement, and personality changes.*

FDA Label Image

Table 2 (Ifu Table 2)

A data table listing four medical conditions in two columns: 'disorientation' and 'seizures' in the header row, with 'unconsciousness' under disorientation and 'death' under seizures in the second row.*

FDA Label Image

Label 1 (Label 1)

Label for Glucagon Emergency Kit for Low Blood Sugar shows Glucagon for Injection, 1 mg (1 unit) dosage form. The label includes Lilly branding and notes it is prescription only. Marketing is by Lilly USA, LLC in Indianapolis. The Glucagon is a product of Austria and the diluting syringe is a product of Germany. NDC 0002-8031-01 is visible.*

FDA Label Image

Label 2 (Label 2)

Label for GLUCAG0N injection kit, showing contents of one vial of glucagon for injection and a diluting solution. The label includes dosage instructions for subcutaneous, intramuscular, or intravenous use in adults and pediatric patients over 20 kg. Manufacturer is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Serialized Label (Serialized Label)

GLUCAG0N emergency treatment kit in a red plastic clamshell container with a white label. The label contains multiple barcode scans and text including the distributor information for HF Acquisition Co., LLC, Mukilteo, WA 98275. The product is marked RX ONLY and includes instructions for use and warnings related to diluting the solution and disposal of unused portions.*

FDA Label Image

Structure (Structure)

Chemical structure diagram showing a sequence of 29 amino acids arranged in a curved chain, labeled from N-terminus (H2N) to C-terminus (COOH). This diagram likely represents the peptide structure related to the active ingredient in GLUCAG0N by HF Acquisition Co LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.